Pharmacoimmunodynamic interactions of interleukin- 10 and prednisone in healthy volunteers

Clinical Pharmacology and Therapeutics

Volumn 65, Issue 3, 1999, Pages 304-318

  Chakraborty, Abhijit ^b   Blum, Robert A ^b   Cutler, David L ^b   Jusko, William J ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 1BETA; PHYTOHEMAGGLUTININ; PLACEBO; PREDNISOLONE; PREDNISONE; RECOMBINANT INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYTOKINE PRODUCTION; CYTOPENIA; DOSE RESPONSE; HUMAN; HUMAN EXPERIMENT; IMMUNOPHARMACOLOGY; LEUKOCYTE DIFFERENTIAL COUNT; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOPENIA; MALE; NEUTROPHILIA; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0033064301     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(99)70110-4     Document Type: Article

References (40)

1. 1. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell; IV: Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989;170:2081-95.
2. 2. de Vries JE. Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann Med 1995;27:537-41.
3. 3. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10 [review]. Annu Rev Immunol 1993;11:165-90.
4. 4. Lalani I, Bhol K, Ahmed AR. Interleukin-10: biology, role in inflammation and autoimmunity. Ann Allergy Asthma Immunol 1997;79:469-84.
5. 5. Wang P, Wu P, Siegel MI, Egan RW, Billah MM. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J Immunol 1994;153:811-6.
6. 6. Taga K, Mostowski H, Tosato G. Human interleukin-10 can directly inhibit T-cell growth. Blood 1993;81:2964-71.
7. 7. Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell 1996;85:307-10.
8. 8. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10 deficient mice develop chronic enterococolitis. Cell 1993;75:263-74.
9. 9. Kang XX, Hirano T, Oka K, Sakura E, Tamaki T, Kozaki M. Altered prednisolone-specific lymphocyte sensitivity in chronic renal failure may play a role of pharmacodynamic marker of acute allograft rejection after kidney transplantation. Eur J Clin Pharmacol 1991;41:417-23.
10. 10. Kasama T, Strieter RM, Lukacs NW, Burdick MD, Kunkel SL. Regulation of neutrophil-derived expression by IL-10. J Immunol 1994;152:3559-69.
11. 11. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-22.
12. 12. Pajkrt D, Camoglio L, Tiel-van Buul MCM, Bruin KDE, Cutler DL, Affrime MB, et al. Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia. J Immunol 1997;158:3971-7.
13. 13. Howard M, Muchamuel T, Andrade S, Menon S. Interleukin-10 protects mice from lethal endotoxemia. J Exp Med 1993;177:1205-8.
14. 14. Bean AGD, Freiberg RA, Andrade S, Menon S, Zlotnik A. Interleukin-10 protects mice against staphylococcal enterotoxin B-induced lethal shock. Infect Immunol 1993;61:4937-9.
15. 15. Huhn RD, Radwanski E, O'Connell SM, Sturgill MG, Clarke L, Cody RP, et al. Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers. Blood 1996;87:699-705.
16. 16. Huhn RD, Radwanski E, Gallo J, Affrime MB, Sabo R, Gonyo G, et al. Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteers. Clin Pharmacol Ther 1997;62:171-80.
17. 17. Radwanski E, Chakraborty A, Wart SV, Huhn RD, Cutler DL, Affrime MB, et al. Pharmacokinetics and leukocyte responses of recombinant human interleukin-10. Pharm Res 1998;15:1895-901.
18. 18. Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 1986;232:977-80.
19. 19. Wauwe JV, Aerts F, Walter H, de Boer M. Cytokine production by phytohemagglutinin-stimulated human blood cells: effects of corticosteroids, T cell immunosuppressants and phosphodiesterase IV inhibitors. Inflamm Res 1995;44:400-5.
20. 20. Steer JH, Vuong Q, Joyce DA. Suppression of human monocyte tumor necrosis factor-α release by glucocorticoid therapy: relationship to systemic monocytopaenia and cortisol suppression. Br J Clin Pharmacol 1997;43:383-9.
21. 21. Lew W, Oppenheim JJ, Matsushima K. Analysis of the suppression of IL-1α and IL-1β production in human peripheral blood mononuclear adherent cells by a glucocorticoid hormone. J Immunol 1988;140:1895-902.
22. 22. Snijdewint FGM, Kapsenberg ML, Wauben-Penris PJJ, Bos JD. Corticosteroids class-dependently inhibit in vitro Th1-and Th2-type cytokine production. Immunopharmacology 1995;29:93-101.
23. 23. Wald JA, Law RM, Ludwig EA, Sloan RR, Middleton E Jr, Jusko WJ. Evaluation of dose-related pharmacokinetics and pharmacodynamics of prednisolone in man. J Pharmacokinet Biopharm 1992;20:567-89.
24. 24. Gillis S, Crabtree GR, Smith K. Glucocorticoid-induced inhibition of T cell growth factor production: I. The effect of mitogen-induced lymphocyte proliferation. J Immunol 1979;123:1624-31.
25. 25. Taga K, Tosato G. IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 1992;148:1143-8.
26. 26. Issekutz AC, Issekutz TB. Quantitation and kinetics of polymorphonuclear leukocyte and lymphocyte accumulation in joints during adjuvant arthritis in the rat. Lab Invest 1991;64:656-63.
27. 27. Leibovich SJ, Ross R. The role of the macrophage in wound repair: a study with hydrocortisone and antimacrophage serum. Am J Pathol 1975;78:71-100.
28. 28. Fauci AS. Mechanisms of corticosteroid action on lymphocyte subpopulations. Immunology 1975;28:669-80.
29. 29. Burton JL, Kehrli ME Jr, Kapil S, Horst RL. Regulation of L-selectin and CD18 on bovine neutrophils by glucocorticoids: effects of cortisol and dexamethasone. J Leukoc Biol 1995;57:317-25.
30. 30. Chakraborty A, Blum RA, Mis SM, Cutler DL, Jusko WJ. Pharmacokinetic and adrenal interactions of IL-10 and prednisone in normal volunteers. J Clin Pharmacol [in press].
31. 31. Piekoszewski W, Chow FS, Jusko WJ. Inhibition of phytohaemagglutinin-induced lymphocyte proliferation by immunosuppressive drugs: use of whole blood culture. Immunopharmacol Immunotoxicol 1994;16:389-401.
32. 32. Dayneka NL, Garg V, Jusko WJ. Comparison of four basic models of indirect pharmacodynamic responses. J Pharmacokinet Biopharm 1993;21:457-78.
33. 33. Milad MA, Ludwig EA, Anne S, Middleton E, Jusko WJ. Pharmacodynamic model for joint exogenous and endogenous corticosteroid suppression of lymphocyte trafficking. J Pharmacokinet Biopharm 1994;22:469-80.
34. 34. Ten Berge RJM, Sauerwein HP, Yong SL, Schellekens PThA. Administration of prednisolone in vivo affects the ratio of OKT4/OKT8 and the LDH-isoenzyme pattern of human T lymphocytes. Clin Immunol Immunopathol 1984;30:91-103.
35. 35. Oosterhuis B, Boxtel CJV. Kinetics of drug effects in man. Ther Drug Monit 1988;10:121-32.
36. 36. Fushimi T, Okayama H, Seki T, Shimura S, Shirato K. Dexamethasone suppressed gene expression and production of interleukin-10 by human peripheral blood mononuclear cells and monocytes. Int Arch Allergy Immunol 1997;112:13-8.
37. 37. Xu ZX, Sun YN, Dubois DC, Almon RR, Jusko WJ. Third-generation model for corticosteroid pharmacodynamics: roles of glucocorticoid receptor mRNA and tyrosine aminotransferase mRNA in rat liver. J Pharmacokinet Biopharm 1995;23:163-81.
38. 38. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995;377: 68-71.
39. 39. Toribio ML, Gutierrez-Ramos JC, Pezzi L, Marcos MAR, Martinez AC. Interleukin-2-dependent autocrine proliferation in T-cell development. Nature 1989;342:82-5.
40. 40. Paalzow LK, Edlund PO. Multiple receptor responses: a new concept to describe the relationship between pharmacological effects and pharmacokinetics of a drug: studies on clonidine in the rat and cat. J Pharmacokinet Biopharm 1979;7:495-510.